Aslan Pharmaceuticals: Case Study of a Start-up in SingaporeHosted By : Niamh Madigan
August 8, 2012
About this Podcast...
Most big pharma are now setting up operations in Asia, with China predicted to be the biggest market in pharmaceuticals by 2025. Mark McHale, Chief Scientific Officer at Aslan Pharmaceuticals discusses the set up of the pharma organisation in Singapore over two years ago, looking at the advantages and indeed challenges of operating in the East and the opportunities that lie ahead certainly from 2020 on.
Have Your Say
Rate this feature and give us your feedback in the comments section below
Taking EDC to the next level: Moving from point solutions to an eClinical ecosystem
April 4, 2013
Guarantee GDP- Compliant Cool Chain Logistics for Pharmaceuticals to CEE & CIS Countries
January 16, 2013
Using Social Media to Drive Product Sales and Grow your Brand
June 28, 2012